Personalised medicine: how the 2011 Multidisciplinary Cancer Congress will mark important milestones in getting the right treatment to the right patient at the right time (2/5)

Share :
Published: 11 Apr 2011
Views: 5208
Michael Baumann - ECCO President & Congress Chair; David Kerr - ESMO President; Anne-Lise Børresen Dale - Scientific Co-Chair (ECCO)
Underpinning the role, relevance and importance of each and every specialty in oncology at the meeing discussants describe the power of multidisciplinarity in advancing cancer research, treatment and care. By anticipating just some of the groundbreaking basic, translational and clinical data they expect to see presented and intermingled in Stockholm, the panel highlights the multidisciplinary and multi-professional scope, appeal and draw of the Congress.